Repligen Corporation operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Repligen with three other
companies in this sector in the United States:
Xtant Medical Holdings Inc
sales of $90.00 million
Nanostring Technologies Inc
Momenta Pharmaceuticals, Inc.
of which 100%
was Drug Products).
Repligen reported sales of $104.54 million
December of 2016.
increase of 25.1%
versus 2015, when the company's sales were $83.54 million.